Sign Up to like & get recommendations! 2
Published in 2019 at "Journal of Cellular Biochemistry"
DOI: 10.1002/jcb.28805
Abstract: Breast cancer (BC) remains a serious health threat for women due to its high incidence and the trend of rejuvenation. Accumulating evidence has highlighted that microRNAs (miRNAs) and messenger RNAs (mRNAs) could play important roles… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Journal of Ultrasound in Medicine"
DOI: 10.1002/jum.14247
Abstract: The purpose of this study is to correlate various features of breast cancers on ultrasound to their histological grade and immunohistochemical biomarkers. read more here.
Sign Up to like & get recommendations! 3
Published in 2022 at "Clinical and Experimental Medicine"
DOI: 10.1007/s10238-021-00781-1
Abstract: Breast cancer (BC) is a common cancer all over the world that affects women. BC is one of the leading causes of cancer mortality in women, which today has decreased with the advancement of technology… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Bioscience reports"
DOI: 10.1042/bsr20212035
Abstract: Breast cancer is a serious malignancy with a high incidence worldwide and a tendency to relapse. The aim of the present study was to identify potential biomarkers in breast cancer using integrated bioinformatics analysis. Microarray… read more here.
Sign Up to like & get recommendations! 2
Published in 2022 at "Seminars in diagnostic pathology"
DOI: 10.1053/j.semdp.2022.06.015
Abstract: Breast cancer represents a heterogeneous group of human cancer at both histological and molecular levels. Estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) are the most commonly used biomarkers… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Endocrine-related cancer"
DOI: 10.1530/erc-16-0490
Abstract: We assessed the associations between changes in total and abdominal fat and changes in biomarkers for breast cancer risk using data of the SHAPE-2 trial. In the SHAPE-2 trial, 243 postmenopausal overweight women were included.… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2022.1035402
Abstract: Breast cancer is the most common cancer in women worldwide and is a substantial public health problem. Screening for breast cancer mainly relies on mammography, which leads to false positives and missed diagnoses and is… read more here.
Sign Up to like & get recommendations! 2
Published in 2022 at "Biomedicines"
DOI: 10.3390/biomedicines10030725
Abstract: Due to the high heterogeneity and initially asymptomatic nature of breast cancer (BC), the management of this disease depends on imaging together with immunohistochemical and molecular evaluations. These tests allow early detection of BC and… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Cancers"
DOI: 10.3390/cancers14030474
Abstract: Simple Summary Epigenetic therapies are promising agents for overcoming clinical resistance to conventional treatments in breast cancer. In the assessed trials, the use of epigenetic therapies for the management of breast cancer has not translated… read more here.